Brown Douglas Matthew 4
4 · NEOGENOMICS INC · Filed Dec 30, 2021
Insider Transaction Report
Form 4
Brown Douglas Matthew
Chief Strategy Officer
Transactions
- Award
Common Stock
2021-12-30+30,572→ 42,216 total
Holdings
- 26,378
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (26,378 underlying) - 45,017
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (45,017 underlying)
Footnotes (3)
- [F1]On December 30, 2021, Mr. Brown was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
- [F2]On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.